Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720177 | SCV000523390 | likely benign | not provided | 2021-03-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551741 | SCV000640897 | benign | Nemaline myopathy 2 | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001720177 | SCV004154149 | likely benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | NEB: BP4, BP7 |
Prevention |
RCV004551454 | SCV004768032 | likely benign | NEB-related disorder | 2020-02-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |